Assessment of the intestinal microbiota and fecal short-chain fatty acids content in children with non-alcoholic fatty liver disease

Authors

  • N.Yu. Zavhorodnia SI “Institute of Gastroenterology of NAMS of Ukraine”, Dnipro, Ukraine
  • O.Yu. Lukianenko SI “Institute of Gastroenterology of NAMS of Ukraine”, Dnipro, Ukraine
  • I.A. Klenina SI “Institute of Gastroenterology of NAMS of Ukraine”, Dnipro, Ukraine
  • O.I. Hrabovska SI “Institute of Gastroenterology of NAMS of Ukraine”, Dnipro, Ukraine
  • O.M. Tatarchuk SI “Institute of Gastroenterology of NAMS of Ukraine”, Dnipro, Ukraine
  • N.S. Vishnarevska SI “Institute of Gastroenterology of NAMS of Ukraine”, Dnipro, Ukraine

DOI:

https://doi.org/10.22141/2308-2097.54.1.2020.199143

Keywords:

non-alcoholic fatty liver disease, short-chain fatty acids, intestinal microflora, children, obesity

Abstract

Background. Changes in the intestinal microbiome trigger the development and progression of non-alcoholic fatty liver disease (NAFLD). Adverse fluctuations in intestinal microbiota are associated with increased intestinal permeability, activation of mucosal and adaptive immunity, increase in production and intestinal absorption of short-chain fatty acids (SCFA). The ratio of acetic, propionic, butyric acid is an important indicator of the integrity of the microbial community of the intestine. Thus, the study of the gut microbiota composition and short-chain fatty acids production represents a very appealing approach to increasing our knowledge about the mechanisms leading to NAFLD in children. The purpose of the study was to determine the features of the fecal short-chain fatty acids (fSCFA) content and the colonic microbiota composition in children with NAFLD. Materials and methods. A comprehensive examination of 102 children was provided in the Department of Pediatric Gastroenterology of the Institute of Gastroenterology of the National Academy of Medical Sciences of Ukraine. According to the presence of obesity, transient elastography data and alanine aminotransferase levels the patients were divided into four groups: I group — children with simple hepatic steatosis (n = 24); II group — children with nonalcoholic steatohepatitis (NASH) (n = 14); III group — children with obesity without steatosis (n = 48), IV group — children with normal weight (n = 16). Chromatographic study of fSCFA was conducted using gas chromatograph Chromatec-Crystal 5000. The microorganisms were identified using a microbiological study of the colon content. Diagnosis of NAFLD was established with FibroScan 502 Touch (Echosens, France) with the determination of the controlled attenuation parameter. Results. Significant changes in the spectrum of fSCFA were observed in children of the III group with acetic acid content increased by 4.8 times (р < 0.05), propionic acid by 1.5 times (р < 0.001), and butyric acid by 1.7 times as compared to the control group, while in children with NASH, acetic content was 2.5-fold increased, propionic and butyric acid — 1.4-fold in comparison with the control group (p = 0.1). Also, significant anaerobic index decrease was observed in NAFLD patients. The fecal content microbiological examination demonstrated the reduced level of Bifidobacteria strains in 11.8 % patients of group I and in 8.3 % of group III; decreased levels of Lactobacillus were found in 70.6 % children of group I, in all children with NASH, in 70.8 % patients of group III. Overgrowth of bacteria such as Klebsiella was identified in 23.5 % patients of group I and in 8.3 % people of group III. Pathogenic Staphylococcus was detected in 5.9 % patients of group I, in 8.3 % patients of group III. Overgrowth of Candida was detected in 23.5 % children of group I, in 14.3 % children of group II and in 20.8 % children of group III. Conclusions. Quantitative and qualitative deviation of intestinal microbiota such as a decrease in the number of major symbionts and an increase in the number of opportunistic microflora was observed in children with NAFLD and obesity. Changes in the SCFA spectrum were found in obese children assuming the importance of intestinal microflora disorders at the early stages of NAFLD development. The estimation of the ratio of SCFA fractions with the anaerobic index calculation can be useful to diagnose intestinal dysbiosis in children with NAFLD.

Downloads

Download data is not yet available.

References

NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet. 2017;390(10113):2627–2642. doi:10.1016/S0140-6736(17)32129-3.

Nobili V, Alisi A, Valenti L, Miele L, Feldstein AE, Alkhouri N. NAFLD in children: new genes, new diagnostic modalities and new drugs. Nat Rev Gastroenterol Hepatol. 2019;16(9):517–530. doi:10.1038/s41575-019-0169-z.

Sharma V, Coleman S, Nixon J, et al. A systematic review and meta-analysis estimating the population prevalence of comorbidities in children and adolescents aged 5 to 18 years. Obes Rev. 2019;20(10):1341–1349. doi:10.1111/obr.12904.

Fang YL, Chen H, Wang CL, Liang L. Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From "two hit theory" to "multiple hit model". World J Gastroenterol. 2018;24(27):2974–2983. doi:10.3748/wjg.v24.i27.2974.

Mirza N, Phan TL, Tester J, et al. A Narrative Review of Medical and Genetic Risk Factors among Children Age 5 and Younger with Severe Obesity. Child Obes. 2018;14(7):443–452. doi:10.1089/chi.2017.0350.

Greber-Platzer S, Thajer A, Bohn S, et al. Increased liver echogenicity and liver enzymes are associated with extreme obesity, adolescent age and male gender: analysis from the German/Austrian/Swiss obesity registry APV. BMC Pediatr. 2019;19(1):332. Published 2019 Sep 12. doi:10.1186/s12887-019-1711-4.

Berardis S, Sokal E. Pediatric non-alcoholic fatty liver disease: an increasing public health issue. Eur J Pediatr. 2014;173(2):131–139. doi:10.1007/s00431-013-2157-6.

Wijarnpreecha K, Lou S, Watthanasuntorn K, et al. Small intestinal bacterial overgrowth and nonalcoholic fatty liver disease: a systematic review and meta-analysis [published online ahead of print, 2019 Sep 16]. Eur J Gastroenterol Hepatol. 2019;10.1097/MEG.0000000000001541. doi:10.1097/MEG.0000000000001541.

Frasinariu OE, Ceccarelli S, Alisi A, Moraru E, Nobili V. Gut-liver axis and fibrosis in nonalcoholic fatty liver disease: an input for novel therapies. Dig Liver Dis. 2013;45(7):543–551. doi:10.1016/j.dld.2012.11.010.

Hatton G, Alterio T, Nobili V, Mann JP. Unmet needs in pediatric NAFLD research: what do we need to prioritize for the future?. Expert Rev Gastroenterol Hepatol. 2018;12(10):961–967. doi:10.1080/17474124.2018.1512853.

Schwimmer JB, Johnson JS, Angeles JE, et al. Microbiome Signatures Associated With Steatohepatitis and Moderate to Severe Fibrosis in Children With Nonalcoholic Fatty Liver Disease. Gastroenterology. 2019;157(4):1109–1122. doi:10.1053/j.gastro.2019.06.028.

Barrea L, Muscogiuri G, Annunziata G, et al. From gut microbiota dysfunction to obesity: could short-chain fatty acids stop this dangerous course?. Hormones (Athens). 2019;18(3):245–250. doi:10.1007/s42000-019-00100-0.

Goffredo M, Mass K, Parks EJ, et al. Role of Gut Microbiota and Short Chain Fatty Acids in Modulating Energy Harvest and Fat Partitioning in Youth. J Clin Endocrinol Metab. 2016;101(11):4367–4376. doi:10.1210/jc.2016-1797.

Hernández MAG, Canfora EE, Jocken JWE, Blaak EE. The Short-Chain Fatty Acid Acetate in Body Weight Control and Insulin Sensitivity. Nutrients. 2019;11(8):1943. Published 2019 Aug 18. doi:10.3390/nu11081943.

Ardatskaya MD, Garushyan GV, Moysak RP, Topchiy TB. Role of short chain fatty acids in evaluation of gut microbiocenosis disorders and their correction in patients with NAFLD of diff erent stages. Experimental and Clinical Gastroenterology. 2019;161(1): 106–116. doi:10.31146/1682-8658-ecg-161-1-106-116. (in Russian).

Michail S, Lin M, Frey MR, et al. Altered gut microbial energy and metabolism in children with non-alcoholic fatty liver disease. FEMS Microbiol Ecol. 2015;91(2):1–9. doi:10.1093/femsec/fiu002.

Alyoshkin VA, Selkova EP, Zatevalov AM, Mironov AYu, Volchetsky AL, Gudova NV. Determination of dysbiotic changes in the gastrointestinal tract by markers of intestinal contents - Federal clinical guidelines. N Novgorod: Publishing House Remediium Volga Region; 2016. 40 p.

Zhao G, Nyman M, Jönsson JA. Rapid determination of short-chain fatty acids in colonic contents and faeces of humans and rats by acidified water-extraction and direct-injection gas chromatography. Biomed Chromatogr. 2006;20(8):674–682. doi:10.1002/bmc.580.

Adamberg K, Adamberg S, Ernits K, et al. Composition and metabolism of fecal microbiota from normal and overweight children are differentially affected by melibiose, raffinose and raffinose-derived fructans. Anaerobe. 2018;52:100–110. doi:10.1016/j.anaerobe.2018.06.009.

Murugesan S, Nirmalkar K, Hoyo-Vadillo C, García-Espitia M, Ramírez-Sánchez D, García-Mena J. Gut microbiome production of short-chain fatty acids and obesity in children. Eur J Clin Microbiol Infect Dis. 2018;37(4):621–625. doi:10.1007/s10096-017-3143-0.

Miele L, Marrone G, Lauritano C, et al. Gut-liver axis and microbiota in NAFLD: insight pathophysiology for novel therapeutic target. Curr Pharm Des. 2013;19(29):5314–5324.

Murugesan S, Ulloa-Martínez M, Martínez-Rojano H, et al. Study of the diversity and short-chain fatty acids production by the bacterial community in overweight and obese Mexican children. Eur J Clin Microbiol Infect Dis. 2015;34(7):1337–1346. doi:10.1007/s10096-015-2355-4.

Downloads

Published

2021-09-06

How to Cite

Zavhorodnia, N., Lukianenko, O., Klenina, I., Hrabovska, O., Tatarchuk, O., & Vishnarevska, N. (2021). Assessment of the intestinal microbiota and fecal short-chain fatty acids content in children with non-alcoholic fatty liver disease. GASTROENTEROLOGY, 54(1), 56–62. https://doi.org/10.22141/2308-2097.54.1.2020.199143

Issue

Section

Original Researches

Most read articles by the same author(s)

1 2 3 4 5 > >>